tradingkey.logo

STAAR Surgical Co

STAA
17.580USD
+0.510+2.99%
Cierre 02/06, 16:00ETCotizaciones retrasadas 15 min
867.64MCap. mercado
PérdidaP/E TTM

STAAR Surgical Co

17.580
+0.510+2.99%

Más Datos de STAAR Surgical Co Compañía

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. The Company markets and sells its ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. Its EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company's newest offering, EVO Viva, has an extended depth of focus (EDoF) optic, which is designed to treat myopia with presbyopia (age-related loss of ability to focus). It also market and sell an ICL lens to treat hyperopia (farsightedness), called Visian ICL. It makes its ICL product offerings available in multiple models, powers and lengths, including some with toric ICL (TICL) versions to correct for astigmatism (blurred vision). The Company’s principal products are ICLs used in refractive surgery, including its EVO family of lenses.

Información de STAAR Surgical Co

Símbolo de cotizaciónSTAA
Nombre de la empresaSTAAR Surgical Co
Fecha de salida a bolsaFeb 24, 1992
Director ejecutivoFarrell (Stephen C)
Número de empleados1157
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 24
Dirección1911 Walker Ave
CiudadMONROVIA
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal91016
Teléfono16263037902
Sitio Webhttps://www.staar.com/
Símbolo de cotizaciónSTAA
Fecha de salida a bolsaFeb 24, 1992
Director ejecutivoFarrell (Stephen C)

Ejecutivos de STAAR Surgical Co

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
67.50K
+20967.00%
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
35.16K
--
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
19.31K
--
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
9.76K
--
Ms. Deborah J. Andrews
Ms. Deborah J. Andrews
Chief Financial Officer
Chief Financial Officer
8.59K
+8586.00%
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
8.19K
-2616.00%
Dr. Elizabeth Yeu, M.D.
Dr. Elizabeth Yeu, M.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
5.10K
+5099.00%
Mr. Louis E. (Lou) Silverman
Mr. Louis E. (Lou) Silverman
Independent Director
Independent Director
475.00
--
Mr. Brian Moore
Mr. Brian Moore
Vice President - Investor Relations and Corporate Development
Vice President - Investor Relations and Corporate Development
--
--
Ms. Lilian Zhou
Ms. Lilian Zhou
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
67.50K
+20967.00%
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
35.16K
--
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
19.31K
--
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
9.76K
--
Ms. Deborah J. Andrews
Ms. Deborah J. Andrews
Chief Financial Officer
Chief Financial Officer
8.59K
+8586.00%
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
8.19K
-2616.00%

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
La empresa aún no ha revelado los datos relevantes.
Por regiónUSD
Nombre
Ganancia
Proporción
China
55.83M
58.94%
Others
22.04M
23.27%
Japan
11.23M
11.85%
U. S.
5.63M
5.95%
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.

Estadísticas de accionistas

Actualizado: lun., 17 de nov
Actualizado: lun., 17 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Broadwood Capital, Inc.
31.07%
BlackRock Institutional Trust Company, N.A.
13.23%
The Vanguard Group, Inc.
8.48%
Yunqi Capital Limited
6.55%
State Street Investment Management (US)
3.84%
Otro
36.83%
Accionistas
Accionistas
Proporción
Broadwood Capital, Inc.
31.07%
BlackRock Institutional Trust Company, N.A.
13.23%
The Vanguard Group, Inc.
8.48%
Yunqi Capital Limited
6.55%
State Street Investment Management (US)
3.84%
Otro
36.83%
Tipos de accionistas
Accionistas
Proporción
Hedge Fund
50.06%
Investment Advisor
34.51%
Investment Advisor/Hedge Fund
18.49%
Research Firm
2.92%
Pension Fund
1.14%
Individual Investor
0.53%
Bank and Trust
0.34%
Insurance Company
0.04%
Sovereign Wealth Fund
0.03%

Participación institucional

Actualizado: jue., 1 de ene
Actualizado: jue., 1 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
534
52.84M
106.24%
-14.23M
2025Q3
511
49.83M
100.45%
-14.96M
2025Q2
543
53.99M
109.59%
-5.64M
2025Q1
586
53.67M
108.47%
-5.73M
2024Q4
611
49.68M
100.75%
-8.34M
2024Q3
633
50.35M
102.36%
-6.37M
2024Q2
636
49.69M
101.15%
-10.70M
2024Q1
632
50.54M
103.45%
-9.24M
2023Q4
640
52.70M
107.96%
-9.84M
2023Q3
658
55.47M
114.38%
-3.16M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Broadwood Capital, Inc.
15.02M
30.19%
--
--
Dec 15, 2025
BlackRock Institutional Trust Company, N.A.
6.58M
13.23%
-133.07K
-1.98%
Sep 30, 2025
The Vanguard Group, Inc.
4.26M
8.56%
-121.64K
-2.78%
Sep 30, 2025
Yunqi Capital Limited
2.50M
5.03%
--
--
Dec 10, 2025
State Street Investment Management (US)
1.91M
3.84%
-91.94K
-4.59%
Sep 30, 2025
Balyasny Asset Management LP
1.81M
3.65%
+1.81M
--
Sep 30, 2025
Magnetar Capital Partners LP
1.20M
2.42%
+1.20M
--
Sep 30, 2025
Geode Capital Management, L.L.C.
1.17M
2.36%
-19.00K
-1.59%
Sep 30, 2025
Goldman Sachs & Company, Inc.
863.00K
1.74%
+745.45K
+634.18%
Sep 30, 2025
Sand Grove Capital Management LLP
829.12K
1.67%
+829.12K
--
Sep 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
AltShares Merger Arbitrage ETF
2.71%
ProShares Merger ETF
2.53%
State Street SPDR S&P Health Care Equipment ETF
1.67%
NYLI Merger Arbitrage ETF
0.87%
Invesco S&P SmallCap Health Care ETF
0.79%
Royce Quant Small-Cap Quality Value ETF
0.26%
State Street SPDR S&P SmallCap 600 ESG ETF
0.13%
iShares S&P Small-Cap 600 Growth ETF
0.1%
State Street SPDR S&P 600 Small Cap Growth ETF
0.1%
iShares ESG Select Screened S&P Small-Cap ETF
0.1%
Ver más
AltShares Merger Arbitrage ETF
Proporción2.71%
ProShares Merger ETF
Proporción2.53%
State Street SPDR S&P Health Care Equipment ETF
Proporción1.67%
NYLI Merger Arbitrage ETF
Proporción0.87%
Invesco S&P SmallCap Health Care ETF
Proporción0.79%
Royce Quant Small-Cap Quality Value ETF
Proporción0.26%
State Street SPDR S&P SmallCap 600 ESG ETF
Proporción0.13%
iShares S&P Small-Cap 600 Growth ETF
Proporción0.1%
State Street SPDR S&P 600 Small Cap Growth ETF
Proporción0.1%
iShares ESG Select Screened S&P Small-Cap ETF
Proporción0.1%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI